Manage the neuropsychiatric manifestations of systemic lupus erythematosus with mostly empirical treatments

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.5, 2012-05, pp. : 11-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropsychiatric Systemic Lupus Erythematosus

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 449-457

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropsychiatric Manifestations in Systemic Lupus Erythematosus: Epidemiology, Pathophysiology and Management

By Postal Mariana Costallat Lilian T.L. Appenzeller Simone

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 721-736

Adis International

Access to resources Recommend Favorite

Anti–U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3730-3740

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1261-1269

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa Perl Andras

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite